SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), also known as novel coronavirus 2019-nCoV, causes fever, severe respiratory illness and can lead to life threatening pneumonia. The first cases of this disease, termed COVID-19 for coronavirus disease 2019 have been detected in December 2019 in Wuhan, China.
SARS-CoV-2 Prot_M stands for the membrane glycoprotein of SARS-CoV-2. This protein is known to shape the viral envelope of coronaviruses and is involved in virion assembly as well as budding. Thus, the membrane glycoprotein (“M”) of SARS-CoV-2 has been suggested as possible target for vaccine development.